Martha Morrell, CHIEF MEDICAL OFFICER at NeuroPace Inc (NPCE), sold 3,200 shares at $15.01 ($48K) on 2025-01-24, disclosed to the SEC on 2025-01-28.
Scheduled sale ($48k) by CHIEF MEDICAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| NPCE | SELL | 2025-01-31 | $5K | — | Filing → |
| NPCE | SELL | 2024-02-06 | $531K | — | Filing → |
| NPCE | SELL | 2024-02-01 | $379K | — | Filing → |